Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3667 | 1935 | 36.5 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
422 | 3 | C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN | 28303 |
1373 | 2 | C REACTIVE PROTEIN//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO | 8199 |
3667 | 1 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO | 1935 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLASGOW PROGNOSTIC SCORE | authKW | 1270515 | 4% | 93% | 87 |
2 | NEUTROPHIL TO LYMPHOCYTE RATIO | authKW | 1221800 | 9% | 45% | 172 |
3 | NEUTROPHIL LYMPHOCYTE RATIO | authKW | 914651 | 7% | 44% | 131 |
4 | PROGNOSTIC NUTRITIONAL INDEX | authKW | 502342 | 2% | 86% | 37 |
5 | PLATELET TO LYMPHOCYTE RATIO | authKW | 375557 | 3% | 45% | 53 |
6 | PLATELET LYMPHOCYTE RATIO | authKW | 360145 | 2% | 53% | 43 |
7 | MODIFIED GLASGOW PROGNOSTIC SCORE | authKW | 253335 | 1% | 94% | 17 |
8 | PLR | authKW | 240511 | 1% | 61% | 25 |
9 | LYMPHOCYTE TO MONOCYTE RATIO | authKW | 219639 | 1% | 61% | 23 |
10 | INFLAMMATION BASED PROGNOSTIC SCORE | authKW | 206174 | 1% | 93% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 25418 | 59% | 0% | 1137 |
2 | Surgery | 1714 | 18% | 0% | 341 |
3 | Gastroenterology & Hepatology | 1514 | 9% | 0% | 177 |
4 | Urology & Nephrology | 812 | 7% | 0% | 129 |
5 | Medicine, Research & Experimental | 128 | 4% | 0% | 82 |
6 | Medicine, General & Internal | 95 | 5% | 0% | 97 |
7 | Medical Laboratory Technology | 60 | 1% | 0% | 23 |
8 | Cell Biology | 38 | 4% | 0% | 87 |
9 | Immunology | 37 | 4% | 0% | 79 |
10 | Respiratory System | 36 | 2% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ROYAL INFIRM | 77824 | 4% | 7% | 68 |
2 | UNIT GENET EPIDEMIOL PHARMACOGENET | 60851 | 0% | 43% | 9 |
3 | JIANGMEN CITY CENT HOSP | 50491 | 0% | 80% | 4 |
4 | RENAL TRANSPORTAT | 47336 | 0% | 100% | 3 |
5 | UNIV SURG | 44314 | 2% | 7% | 42 |
6 | CLIN RADIOTHER EUT ONCOL | 31558 | 0% | 100% | 2 |
7 | HLTH BEHAV SCI HLTH EDUC | 31558 | 0% | 100% | 2 |
8 | ZHONGSHAN CITY PEOPLES HOSP | 31554 | 0% | 50% | 4 |
9 | MOL FRONTIER SURG | 28399 | 0% | 60% | 3 |
10 | JIANGMEN HOSP | 28047 | 0% | 44% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOTARGETS AND THERAPY | 12515 | 2% | 2% | 39 |
2 | ANNALS OF SURGICAL ONCOLOGY | 6398 | 3% | 1% | 54 |
3 | BRITISH JOURNAL OF CANCER | 6264 | 4% | 0% | 85 |
4 | TUMOR BIOLOGY | 5605 | 2% | 1% | 47 |
5 | CANCER BIOMARKERS | 5010 | 1% | 2% | 14 |
6 | MEDICAL ONCOLOGY | 4875 | 2% | 1% | 32 |
7 | BMC CANCER | 4347 | 2% | 1% | 45 |
8 | MEDICINE | 3690 | 2% | 1% | 41 |
9 | CLINICAL GENITOURINARY CANCER | 3298 | 1% | 2% | 12 |
10 | ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 3199 | 2% | 1% | 34 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TEMPLETON, AJ , MCNAMARA, MG , SERUGA, B , VERA-BADILLO, FE , ANEJA, P , OCANA, A , LEIBOWITZ-AMIT, R , SONPAVDE, G , KNOX, JJ , TRAN, B , ET AL (2014) PROGNOSTIC ROLE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN SOLID TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 106. ISSUE 6. P. - | 86 | 83% | 185 |
2 | SHROTRIYA, S , WALSH, D , BENNANI-BAITI, N , THOMAS, S , LORTON, C , (2015) C-REACTIVE PROTEIN IS AN IMPORTANT BIOMARKER FOR PROGNOSIS TUMOR RECURRENCE AND TREATMENT RESPONSE IN ADULT SOLID TUMORS: A SYSTEMATIC REVIEW.PLOS ONE. VOL. 10. ISSUE 12. P. - | 145 | 63% | 8 |
3 | GUTHRIE, GJK , CHARLES, KA , ROXBURGH, CSD , HORGAN, PG , MCMILLAN, DC , CLARKE, SJ , (2013) THE SYSTEMIC INFLAMMATION-BASED NEUTROPHIL-LYMPHOCYTE RATIO: EXPERIENCE IN PATIENTS WITH CANCER.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 88. ISSUE 1. P. 218-230 | 57 | 90% | 183 |
4 | MCMILLAN, DC , (2013) THE SYSTEMIC INFLAMMATION-BASED GLASGOW PROGNOSTIC SCORE: A DECADE OF EXPERIENCE IN PATIENTS WITH CANCER.CANCER TREATMENT REVIEWS. VOL. 39. ISSUE 5. P. 534-540 | 60 | 82% | 163 |
5 | ROXBURGH, CSD , MCMILLAN, DC , (2010) ROLE OF SYSTEMIC INFLAMMATORY RESPONSE IN PREDICTING SURVIVAL IN PATIENTS WITH PRIMARY OPERABLE CANCER.FUTURE ONCOLOGY. VOL. 6. ISSUE 1. P. 149 -163 | 75 | 63% | 280 |
6 | WANG, ZX , CAO, Y , ZHANG, G , JIANG, CP , (2016) PROGNOSTIC VALUE OF SIMPLE INFLAMMATION BASED MARKERS IN HEPATOCELLULAR CARCINOMA.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. VOL. 9. ISSUE 11. P. 20727 -20740 | 73 | 77% | 0 |
7 | PARAMANATHAN, A , SAXENA, A , MORRIS, DL , (2014) A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE IMPACT OF PRE-OPERATIVE NEUTROPHIL LYMPHOCYTE RATIO ON LONG TERM OUTCOMES AFTER CURATIVE INTENT RESECTION OF SOLID TUMOURS.SURGICAL ONCOLOGY-OXFORD. VOL. 23. ISSUE 1. P. 31 -39 | 47 | 81% | 47 |
8 | KIM, HS , KU, JH , (2016) SYSTEMIC INFLAMMATORY RESPONSE BASED ON NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A PROGNOSTIC MARKER IN BLADDER CANCER.DISEASE MARKERS. VOL. . ISSUE . P. - | 61 | 77% | 0 |
9 | BUGADA, D , ALLEGRI, M , LAVAND'HOMME, P , DE KOCK, M , FANELLI, G , (2014) INFLAMMATION-BASED SCORES: A NEW METHOD FOR PATIENT-TARGETED STRATEGIES AND IMPROVED PERIOPERATIVE OUTCOME IN CANCER PATIENTS.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 62 | 70% | 12 |
10 | MELLING, N , GRUNING, A , TACHEZY, M , NENTWICH, M , REEH, M , UZUNOGLU, FG , VASHIST, YK , IZBICKI, JR , BOGOEVSKI, D , (2016) GLASGOW PROGNOSTIC SCORE MAY BE A PROGNOSTIC INDEX FOR OVERALL AND PERIOPERATIVE SURVIVAL IN GASTRIC CANCER WITHOUT PERIOPERATIVE TREATMENT.SURGERY. VOL. 159. ISSUE 6. P. 1548 -1556 | 52 | 80% | 0 |
Classes with closest relation at Level 1 |